Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people.

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Abstract Text:

P H Canter,E Ernst,P H Canter,E Ernst,

Here, we update our earlier systematic review of 2001, which critically evaluated the data from clinical trials to determine whether Ginkgo biloba enhances cognitive function in healthy subjects. Literatures searches of six computerised databases, updated to January 2007, were made for randomised, placebo-controlled, double-blind clinical trials of the effects of standardised Ginkgo biloba (G. biloba) extracts on cognitive function in healthy subjects under the age of 60 years. Trials published in any language were included, and data were extracted independently by the two authors following a standardised protocol. We include 15 randomised clinical trials of which 7 are single-dose studies and 8 are longer term studies with treatment periods ranging from 2 days to 13 weeks. Three single dose studies and 4 longer term studies are newly included. Several of the studies have methodological flaws. A number of the acute studies used multiple outcomes and report positive effects on one or more of these at particular time points with particular doses but these findings are either not replicated, or are directly contradicted by other studies. The evidence from longer term studies is largely negative. Of those studies which measured subjective effects, only one of five acute studies and one of six longer term studies reported any significant positive results. Overall, and in line with our previous conclusions, we have found no convincing evidence from randomised clinical trials for a robust positive effect of G. biloba ingestion upon any aspect of cognitive function in healthy young people, after either acute or longer term administration.

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Publishing Authors By Initials

PH Canter,E Ernst,PH Canter,E Ernst,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Journal Published:

PUBLICATION TYPE: Review

Journal: Human psychopharmacology

VOLUME: 22

Page Numbers: 265-78

Journal Abbreviation:

ISSN: 0885-6222

DAY: 4

MONTH: Jul

YEAR: 2007

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Information

Number of References: 27

LANGUAGE: eng

NlmUniqueID: 8702539

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people.

AFFILIATION: Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, Exeter, UK. peter.canter@pms.ac.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hum Psychopharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G biloba extracts in healthy people Related Publications

• A direction for value in health.
• A re-evaluation of kava (Piper methysticum).
• Adolescents in smoking cessation treatment: relationship between externalizing symptoms, smoking history and outcome.
• An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
• Attention alters neural responses to evocative faces in behaviorally inhibited adolescents.
• Boltzmann equation for dissipative gases in homogeneous states with nonlinear friction.
• Central airway mechanics and flow limitation in acquired tracheobronchomalacia.
• Cochlear implantation in patients with chronic otitis: indications for subtotal petrosectomy and obliteration of the middle ear.
• Codominance of TLR2-dependent and TLR2-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo.
• Cost-effectiveness of complementary therapies in the United kingdom-a systematic review.
• Different activation patterns for working memory load and visual attention load.
• Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people.
• Ginkgo biloba: a smart drug? A systematic review of controlled trials of the cognitive effects of ginkgo biloba extracts in healthy people.
• Homeopathy for cancer?
• Johrei family healing: a pilot study.
• Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors.
• LspA-independent action of globomycin on Mycobacterium tuberculosis.
• Mimetics of the tri- and tetrasaccharide epitope of GQ1balpha as myelin-associated glycoprotein (MAG) ligands.
• Publication bias in complementary/alternative medicine.
• Regulation of Mycobacterium tuberculosis whiB3 in the mouse lung and macrophages.
• Solid-state 13C NMR and quantum chemical investigation of metal diene complexes.
• Stomatococcus mucilaginosus meningitis in a patient with acute lymphoblastic leukemia.
• Structural heterogeneity and environmentally regulated remodeling of Francisella tularensis subspecies novicida lipid A characterized by tandem mass spectrometry.
• Study by Robertson et al is a fine example of nonsensical, misleading statistics.
• The fascination of complementary and alternative medicine (CAM).
• The structure and function of Francisella lipopolysaccharide.
• Three-year developmental outcomes in children with prenatal alcohol and drug exposure.
• Transcriptional and physiological adaptation to defective protein-O-mannosylation in Candida albicans.
• Unified structural equation modeling approach for the analysis of multisubject, multivariate functional MRI data.
• Zeolite SSZ-53: an extra-large-pore zeolite with interesting catalytic properties.